НовостиBenzingaJP Morgan Initiates Coverage On Iambic Therapeutics with Overweight Rating, Announces Price Target of $22 JP Morgan Initiates Coverage On Iambic Therapeutics with Overweight Rating, Announces Price Target of $22 Benzinga 2026.11.09 13:10 (GMT+0) Открыть на Benzinga Другие новости